
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier
Nazneen Pathan, Pravin Shende
Journal of Controlled Release (2021) Vol. 335, pp. 398-407
Closed Access | Times Cited: 30
Nazneen Pathan, Pravin Shende
Journal of Controlled Release (2021) Vol. 335, pp. 398-407
Closed Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Advanced Nanoparticle Engineering for Precision Therapeutics of Brain Diseases
Muhammad Ismail, Jiayi Liu, Ningyang Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123138-123138
Closed Access | Times Cited: 2
Muhammad Ismail, Jiayi Liu, Ningyang Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123138-123138
Closed Access | Times Cited: 2
Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles
Jain Koo, Yuseon Shin, Hyewon Jeon, et al.
Journal of Controlled Release (2025) Vol. 378, pp. 997-1012
Closed Access | Times Cited: 1
Jain Koo, Yuseon Shin, Hyewon Jeon, et al.
Journal of Controlled Release (2025) Vol. 378, pp. 997-1012
Closed Access | Times Cited: 1
Challenges and Material Innovations in Drug Delivery to Central Nervous System Tumors
Zhenyu Gong, Dairan Zhou, Dejun Wu, et al.
Biomaterials (2025) Vol. 319, pp. 123180-123180
Closed Access | Times Cited: 1
Zhenyu Gong, Dairan Zhou, Dejun Wu, et al.
Biomaterials (2025) Vol. 319, pp. 123180-123180
Closed Access | Times Cited: 1
Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia
Alisa Vollhardt, Lutz Froelich, Anna Stockbauer, et al.
Neurobiology of Disease (2025), pp. 106845-106845
Open Access | Times Cited: 1
Alisa Vollhardt, Lutz Froelich, Anna Stockbauer, et al.
Neurobiology of Disease (2025), pp. 106845-106845
Open Access | Times Cited: 1
Recommendations on the use of azole antifungals in hematology-oncology patients
José Ramón Azanza Perea, José Mensa, José Barberán, et al.
Revista Española de Quimioterapia (2023) Vol. 36, Iss. 3, pp. 236-258
Open Access | Times Cited: 19
José Ramón Azanza Perea, José Mensa, José Barberán, et al.
Revista Española de Quimioterapia (2023) Vol. 36, Iss. 3, pp. 236-258
Open Access | Times Cited: 19
Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight
Shovit Ranjan, Akash Gautam
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 19
Shovit Ranjan, Akash Gautam
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 19
Effective Action of Silymarin against Ketamine-induced Schizophrenia in Male Mice: Insight into the Biochemical and Molecular Mechanisms of Action
Benneth Ben‐Azu, Aliance Romain Fokoua, Olajide S. Annafi, et al.
Journal of Psychiatric Research (2024) Vol. 179, pp. 141-155
Closed Access | Times Cited: 6
Benneth Ben‐Azu, Aliance Romain Fokoua, Olajide S. Annafi, et al.
Journal of Psychiatric Research (2024) Vol. 179, pp. 141-155
Closed Access | Times Cited: 6
Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment
Xiaohan Guo, Yi Wu, Xue Ying, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Xiaohan Guo, Yi Wu, Xue Ying, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Advances in Nanomedicines: A Promising Therapeutic Strategy for Ischemic Cerebral Stroke Treatment
Jun Li, Fei Xie, Xuemei Ma
Nanomedicine (2024) Vol. 19, Iss. 9, pp. 811-835
Closed Access | Times Cited: 5
Jun Li, Fei Xie, Xuemei Ma
Nanomedicine (2024) Vol. 19, Iss. 9, pp. 811-835
Closed Access | Times Cited: 5
Nanomedicines for intranasal delivery: understanding the nano-bio interactions at the nasal mucus-mucosal barrier
T.S. Hua, Shuling Li, Bing Han
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 553-572
Closed Access | Times Cited: 5
T.S. Hua, Shuling Li, Bing Han
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 553-572
Closed Access | Times Cited: 5
Electrochemical immunosensor based on AuNPs/ERGO@CNT nanocomposites by one-step electrochemical co-reduction for sensitive detection of P-glycoprotein in serum
Taicheng Lu, Yi‐Ming Sun, Yu Lin Zhong, et al.
Biosensors and Bioelectronics (2022) Vol. 222, pp. 115001-115001
Closed Access | Times Cited: 21
Taicheng Lu, Yi‐Ming Sun, Yu Lin Zhong, et al.
Biosensors and Bioelectronics (2022) Vol. 222, pp. 115001-115001
Closed Access | Times Cited: 21
The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discovery
Benoit Cox, Johan Nicolaï, Beth Williamson
Biopharmaceutics & Drug Disposition (2022) Vol. 44, Iss. 1, pp. 113-126
Closed Access | Times Cited: 20
Benoit Cox, Johan Nicolaï, Beth Williamson
Biopharmaceutics & Drug Disposition (2022) Vol. 44, Iss. 1, pp. 113-126
Closed Access | Times Cited: 20
Interactions between ABC gene polymorphisms and processing speed in predicting depression severity
Meijiang Jin, Lei Ji, Maojia Ran, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Meijiang Jin, Lei Ji, Maojia Ran, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Reversing Morphine Induced Tolerance: Insights into Cetirizine and Green Tea Extract Efficacy.
Tahereh Eteraf-Oskouei, Adel Mahmoudi Gharehbaba, Solmaz Asnaashari, et al.
Current Therapeutic Research (2025), pp. 100783-100783
Open Access
Tahereh Eteraf-Oskouei, Adel Mahmoudi Gharehbaba, Solmaz Asnaashari, et al.
Current Therapeutic Research (2025), pp. 100783-100783
Open Access
Targeting EGFR and PI3K/mTOR pathways in glioblastoma: innovative therapeutic approaches
Gursimran Singh, Rohit Rohit, Pankaj Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Gursimran Singh, Rohit Rohit, Pankaj Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Synthesis and Pharmacological Characterization of Novel Peripheral Cannabinoid-1 Receptor Blockers Based on a Tricyclic Scaffold
Asaad Gammal, Taher Nassar, Yael Soae, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Asaad Gammal, Taher Nassar, Yael Soae, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Bio‐Nano Innovations Targeting the Neurovascular Complex for Epilepsy Treatment
Xin Wang, Yikang Cheng, Zhenghan Qi, et al.
Advanced Healthcare Materials (2025)
Closed Access
Xin Wang, Yikang Cheng, Zhenghan Qi, et al.
Advanced Healthcare Materials (2025)
Closed Access
In Silico, In Vitro, and Ex Vivo Biological Activity of Some Novel Mebeverine Precursors
Miglena Milusheva, Vera Gledacheva, Iliyana Stefanova, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 605-605
Open Access | Times Cited: 10
Miglena Milusheva, Vera Gledacheva, Iliyana Stefanova, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 605-605
Open Access | Times Cited: 10
Second Near‐Infrared Activatable Nitric Oxide Releasing Nanoactuators for Photothermal Combinational Modulation of Epileptogenic Focus
Jiansheng Liu, Jiajia Li, Yanhui Shi, et al.
Small Structures (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 3
Jiansheng Liu, Jiajia Li, Yanhui Shi, et al.
Small Structures (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 3
Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery
Roohi Mohi-ud-din, Reyaz Hassan Mir, Prince Ahad Mir, et al.
Current Drug Metabolism (2022) Vol. 23, Iss. 9, pp. 735-756
Closed Access | Times Cited: 14
Roohi Mohi-ud-din, Reyaz Hassan Mir, Prince Ahad Mir, et al.
Current Drug Metabolism (2022) Vol. 23, Iss. 9, pp. 735-756
Closed Access | Times Cited: 14
Potential of nanocarriers using ABC transporters for antimicrobial resistance
Ragini Amarnani, Amey Revdekar, Bhagyashree V. Salvi, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103570-103570
Closed Access | Times Cited: 7
Ragini Amarnani, Amey Revdekar, Bhagyashree V. Salvi, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103570-103570
Closed Access | Times Cited: 7
Recent advances towards overcoming the blood–brain barrier
Amna Ali, Muhammad Sohail Arshad, Mahtab Ahmad Khan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103735-103735
Closed Access | Times Cited: 7
Amna Ali, Muhammad Sohail Arshad, Mahtab Ahmad Khan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103735-103735
Closed Access | Times Cited: 7
Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function
Sébastien Goutal, Anthony Novell, Sarah Leterrier, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 483-492
Open Access | Times Cited: 6
Sébastien Goutal, Anthony Novell, Sarah Leterrier, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 483-492
Open Access | Times Cited: 6
Thiolated Chitosan-Centella asiatica Nanocomposite: A Potential Brain Targeting Strategy Through Nasal Route
Hajira Haroon, Dhrubojyoti Mukherjee, Jayaraman Anbu, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 8
Closed Access | Times Cited: 13
Hajira Haroon, Dhrubojyoti Mukherjee, Jayaraman Anbu, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 8
Closed Access | Times Cited: 13
Novel Soloxolone Amides as Potent Anti-Glioblastoma Candidates: Design, Synthesis, In Silico Analysis and Biological Activities In Vitro and In Vivo
Andrey V. Markov, Anna A. Ilyina, Oksana V. Salomatina, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 603-603
Open Access | Times Cited: 9
Andrey V. Markov, Anna A. Ilyina, Oksana V. Salomatina, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 603-603
Open Access | Times Cited: 9